JLK Inc Cash Flow Conversion Efficiency
JLK Inc cash flow conversion efficiency. Based on the latest financial reports, JLK Inc (322510) has a cash flow conversion efficiency ratio of -0.056x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-1.94 Billion ≈ $-1.32 Million USD) by net assets (₩34.70 Billion ≈ $23.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of JLK Inc (2017–2025)
Cash flow conversion efficiency of JLK Inc from 2017 to 2025. This chart illustrates how JLK Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 322510 live share price for real-time trading data and today's change.
JLK Inc Cash Flow Conversion Ratio Explained
JLK Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
JLK Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JLK Inc ranked by their cash flow conversion efficiency. Also see JLK Inc stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Renergen Ltd.
JSE:REN
|
-0.171x |
|
Isik Plastik Sanayi ve Dis Ticaret Pazarlama AS
IS:ISKPL
|
N/A |
|
Notion Vtec Bhd
KLSE:0083
|
0.037x |
|
Y-Entec Co. Ltd
KQ:067900
|
0.026x |
|
SanDi Properties Co Ltd
TW:1438
|
-0.004x |
|
Mastech Holdings Inc
NYSE MKT:MHH
|
0.074x |
|
WeConnect
PA:ALWEC
|
0.183x |
|
Hanjin Heavy Ind & Const Holdings Co Ltd
KO:003480
|
0.039x |
Annual Cash Flow Conversion Efficiency for JLK Inc (2017–2025)
The table below shows the annual cash flow conversion efficiency of JLK Inc from 2017 to 2025. Review JLK Inc (322510) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩41.36 Billion ≈ $28.03 Million |
₩-12.34 Billion ≈ $-8.36 Million |
-0.298x | -34.56% |
| 2024-12-31 | ₩49.32 Billion ≈ $33.42 Million |
₩-10.94 Billion ≈ $-7.41 Million |
-0.222x | +59.24% |
| 2023-12-31 | ₩11.72 Billion ≈ $7.95 Million |
₩-6.38 Billion ≈ $-4.32 Million |
-0.544x | -14.45% |
| 2022-12-31 | ₩16.62 Billion ≈ $11.26 Million |
₩-7.90 Billion ≈ $-5.35 Million |
-0.475x | -87.81% |
| 2021-12-31 | ₩24.08 Billion ≈ $16.32 Million |
₩-6.10 Billion ≈ $-4.13 Million |
-0.253x | -88.59% |
| 2020-12-31 | ₩30.67 Billion ≈ $20.78 Million |
₩-4.12 Billion ≈ $-2.79 Million |
-0.134x | +24.14% |
| 2019-12-31 | ₩36.30 Billion ≈ $24.60 Million |
₩-6.42 Billion ≈ $-4.35 Million |
-0.177x | +71.77% |
| 2018-12-31 | ₩6.10 Billion ≈ $4.13 Million |
₩-3.82 Billion ≈ $-2.59 Million |
-0.627x | -268.97% |
| 2017-12-31 | ₩-8.64 Billion ≈ $-5.86 Million |
₩-3.21 Billion ≈ $-2.17 Million |
0.371x | -- |
About JLK Inc
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatme… Read more